• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM VITAMIN B12 (VB12) ASSAY; RADIOASSAY, VITAMIN B12

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ATELLICA IM VITAMIN B12 (VB12) ASSAY; RADIOASSAY, VITAMIN B12 Back to Search Results
Model Number N/A
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/07/2023
Event Type  malfunction  
Manufacturer Narrative
The customer from outside the united states reports observation of discordant elevated multiple patient(s) sample results for vitamin b12 (vb12) assay, lot 290 when tested with atellica im 1600 analyzer.The initial results were not reported to the physician(s).The samples were repeated on multiple atellica im analyzers and lower results were obtained.The interpretation of results section of the atellica im vitamin b12 (vb12) instructions for use states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." siemens healthcare diagnostics is investigating.
 
Event Description
The customer observed discordant elevated multiple patient(s) sample results for vitamin b12 (vb12) assay, lot 290 when tested with atellica im 1600 analyzer.The initial results were not reported to the physician(s).The samples were repeated on multiple atellica im analyzers and lower results were obtained.There are no allegations of patient harm, changes in treatment, or delays in diagnosis in association with the observed elevated vitamin b12 (vb12) results.
 
Manufacturer Narrative
Initial mdr 1219913-2023-00157 was filed on aug 07, 2023.Additional information ¿ sep 06, 2023: the customer from outside the united states reported the initial issue as multiple discordant patient results on vitamin b12 (vb12) on atellica im 1600 instrument (ih0600).Siemens investigation included an assessment of reagent, instrument, and sample data.Siemens reviewed all data provided in escalation documentation to include quality control (qc), calibration, and patient sample results.Reagent issues were unable to be ruled out based on review of quality control (qc) which showed recovery was not within acceptable ranges for the reagent pack and ancillary pack combination used on with one of the patient samples (lot 290 p01329010164975 /2194 a01372194034704).Siemens reviewed the reagent and ancillary usage during the reported discordant samples, it was found that multiple packs of reagent and ancillary reagent were in use on this atellica im.Due to multiple reagent packs in use at the time of the discordant results and quality control (qc) out of range, siemens is unable to verify appropriate handling of vb12 reagent packs during the onboard stability of the reagent.Siemens also cannot rule out preanalytical handling of the patient samples as the cause of the discordant patient results at the customer site.Multiple patient samples were run before and after the samples in question on the same reagent and ancillary packs without any error or discordant results.There is a potential that when a customer may have insufficiently mixed the dtt reagent during preparation, allowed reagent to sit before placing in reagent compartment or diverged from appropriate volumes during manual reagent preparation, discordant results may occur.The customer should review proper preparation and handling of the dtt/releasing agent as directed in the atellica im vb12 information for use (ifu).Return of the patient sample for further investigation is not warranted because discordant results were not reproducible.The issue was resolved with routine troubleshooting.In section h6, the investigation finding and investigation conclusion codes were updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATELLICA IM VITAMIN B12 (VB12) ASSAY
Type of Device
RADIOASSAY, VITAMIN B12
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict ave
tarrytown NY 10591 5097
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC
333 coney street
east walpole MA 02032
Manufacturer Contact
louise mclaughlin
333 coney street
east walpole, MA 02032
7818564812
MDR Report Key17470207
MDR Text Key321530056
Report Number1219913-2023-00157
Device Sequence Number1
Product Code CDD
UDI-Device Identifier00630414600284
UDI-Public00630414600284
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K993571
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/15/2024
Device Model NumberN/A
Device Catalogue Number10995715
Device Lot Number290
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/13/2023
Initial Date FDA Received08/07/2023
Supplement Dates Manufacturer Received09/06/2023
Supplement Dates FDA Received09/25/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/15/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-